Curaleaf Holdings, Inc. (TSX: CURA)
Health Care · Pharmaceuticals · US
CA$13.19
-3.93% today · +9.8% 1Y
Curaleaf Holdings, Inc. (TSX: CURA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.64B and employs 5,554 people.
Over the last twelve months the share price has gained 9.8%, trading between 7.77 and 20.93.
Tweenvest scores Curaleaf Holdings, Inc. across four factors: quality 48/100, value 51/100, growth 33/100. Its strongest factor is value.
CURA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.64B
- Revenue (TTM)
- $1.32B
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- 1.63
- 52-week high
- CA$20.93
- 52-week low
- CA$7.77
- Avg volume (3M)
- —
- Shares outstanding
- 264.81M
- Employees
- 5,554
- Next earnings
- —
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. operates as a prominent cannabis company primarily within the United States, managing its business through both domestic and international operating segments. The company's core activities involve the cultivation, production, and distribution of a diverse range of cannabis products, available through both its retail locations and wholesale channels. Its extensive product catalog includes various cannabis forms such as flowers (e.g., pre-rolls, dry-herb vaporizer cartridges), concentrates for vaping (like pre-filled cartridges and disposable pens), concentrates for dabbing (including distillate droppers), edibles, mints, topical balms, lotions, tinctures, lozenges, and capsules. Additionally, Curaleaf provides hemp-derived CBD and cannabigerol products. Established in 2010, the company is headquartered in New York, New York.
- ISIN
- CA23126M3003
- Listed since
- Apr 7, 2021
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.